Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases

被引：68

作者：

Claridge, Stephen ^{[1
]}

Raeppel, Franck ^{[1
]}

Granger, Marie-Claude ^{[1
]}

Bernstein, Naomy ^{[1
]}

Saavedra, Oscar ^{[1
]}

Zhan, Lijie ^{[1
]}

Llewellyn, David ^{[1
]}

Wahhab, Amal ^{[1
]}

Deziel, Robert ^{[1
]}

Rahil, Jubrail ^{[3
]}

Beaulieu, Normand ^{[2
]}

Nguyen, Hannah ^{[2
]}

Dupont, Isabelle ^{[2
]}

Barsalou, Annie ^{[2
]}

Beaulieu, Carole ^{[2
]}

Chute, Ian ^{[2
]}

Gravel, Serge ^{[2
]}

Robert, Marie-France ^{[2
]}

Lefebvre, Sylvain ^{[2
]}

Dubay, Marja ^{[2
]}

Pascal, Roussen ^{[4
]}

Gillespie, Jeff ^{[4
]}

Jin, Zhiyun ^{[4
]}

Wang, James ^{[4
]}

Besterman, Jeffrey M. ^{[2
]}

MacLeod, A. Robert ^{[2
]}

Vaisburg, Arkadii ^{[1
]}

机构：

[1] MethylGene Inc, Dept Med Chem, Montreal, PQ H4S 2A1, Canada

[2] MethylGene Inc, Dept Cell Biol & Pharmacol, Montreal, PQ H4S 2A1, Canada

[3] MethylGene Inc, Dept Lead Discovery, Montreal, PQ H4S 2A1, Canada

[4] MethylGene Inc, Dept PK Analyt Chem, Montreal, PQ H4S 2A1, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 09期

关键词：

c-Met; VEGFR2; kinase; thieno[3,2-b]pyridine; cancer;

D O I：

10.1016/j.bmcl.2008.04.009

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases is described. The compounds demonstrated potency with IC50 values in the low nanomolar range in vitro while the lead compound also showed in vivo activity against various human tumor xenograft models in mice. Further exploration of this class of compounds is underway. (c) 2008 Elsevier Ltd. All rights reserved.

引用

页码：2793 / 2798

页数：6

共 39 条

[21] Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprints
Damghani, Tahereh
Mashayekh, Korosh
Pirhadi, Somayeh
Firuzi, Omidreza
Sharifi, Shahrzad
Edraki, Najmeh
Khoshneviszadeh, Mehdi
Avestan, Mohammad Sadegh
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2019, 39 (04) : 295 - 303
[22] Discovery of 3H-Imidazo[4,5-b]pyridines as Potent c-Met Kinase Inhibitors: Design, Synthesis, and Biological Evaluation
Chen, Danqi
Wang, Ying
Ma, Yuchi
Xiong, Bing
Ai, Jing
Chen, Yi
Geng, Meiyu
Shen, Jingkang
CHEMMEDCHEM, 2012, 7 (06) : 1057 - 1070
[23] Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors
Zhang, Dengyou
Zhang, Xiaowei
Ai, Jing
Zhai, Yun
Liang, Zhongjie
Wang, Ying
Chen, Yi
Li, Chunpu
Zhao, Fei
Jiang, Hualiang
Geng, Meiyu
Luo, Cheng
Liu, Hong
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (21) : 6804 - 6820
[24] Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Alsehli, Mosa
Ali, Adeeb Al Sheikh
Nafie, Mohamed S.
Bardaweel, Sanaa
Aljuhani, Ateyatallah
Darwish, Khaled M.
Alraqa, Shaya Yahya
Rezki, Nadjet
Aouad, Mohamed Reda
BIOORGANIC CHEMISTRY, 2025, 155
[25] Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2
Xu, Hongchuang
Wang, Minshu
Wu, Fengxu
Zhuo, Linsheng
Huang, Wei
She, Nengfang
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (12)
[26] Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4] triazoles as potent tubulin polymerization inhibitors
Li, Na
Guan, Qi
Hong, Yilang
Zhang, Bowen
Li, Mi
Li, Xuewen
Li, Bo
Zhang, Weige
Wu, Lan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 256
[27] Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series
Liu, Longbin
Norman, Mark H.
Lee, Matthew
Xi, Ning
Siegmund, Aaron
Boezio, Alessandro A.
Booker, Shon
Choquette, Debbie
D'Angelo, Noel D.
Germain, Julie
Yang, Kevin
Yang, Yajing
Zhang, Yihong
Bellon, Steven F.
Whittington, Douglas A.
Harmange, Jean-Christophe
Dominguez, Celia
Kim, Tae-Seong
Dussault, Isabelle
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) : 1868 - 1897
[28] Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase
Zhao, Fei
Zhang, Jing
Zhang, Leduo
Hao, Yu
Shi, Chen
Xia, Guangxin
Yu, Jianxin
Liu, Yanjun
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (18) : 4281 - 4290
[29] Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors
Liu, Na
Wang, Yanfen
Huang, Gongchao
Ji, Conghui
Fan, Wei
Li, Haitao
Cheng, Ying
Tian, Hongqi
BIOORGANIC CHEMISTRY, 2016, 65 : 146 - 158
[30] Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors
Li, Sai
Zhao, Yanfang
Wang, Kewen
Gao, Yali
Han, Jianming
Cui, Bingbing
Gong, Ping
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (11) : 2843 - 2855

← 1 2 3 4 →